Griffin: Accessing functional antibodies from serum without B cells
Griffin is a platform for sequencing polyclonal antibodies using mass spectrometry. Since 2009, Abterra Biosciencs founders and employees have been developing novel methods for sequencing antibody proteins directly. Our monoclonal antibody sequencing service, Valens, has been used to successfully sequence hundreds of antibodies without the need for B cells. Now, with Griffin, we can sequencing complex mixes of antibodies directly from patient serum, or from immunized animals.
Watch our CEO, Dr. Natalie Castellana’s presentation on Unlocking the Serum Antibody Repertoire: Accessing Functional Antibodies without B Cells to learn how Griffin works.
Click below to watch the presentation.
Related Posts
Why Sequence My Antibody Protein?
Why should I sequence my antibody protein? Abterra Bio gives the top reasons to sequence your antibody protein.
Case Study: Alicanto Discovers High Affinity Rabbit Antibodies to Detect Neurofibromin
Infixion Bioscience and Abterra Bio set out to develop high affinity neurofibromin antibody reagents to detect NF1.
Customer Spotlight: Dr. Matthew Burchill
Dr. Burchill explains how Valens rescued his antibody and enabled him to continue his research. De novo antibody sequencing case study.
Get In Touch